|
End-of-day quote
Dhaka S.E.
05/11/2026
|
5-day change | 1st Jan Change | ||
| 238.20 BDT | +8.62% |
|
+4.84% | -30.29% |
| Market Cap | 6.37B 51.17M 45.6M 41.71M 37.99M 71.6M 4.84B 73.53M 501M 200M 2.56B 192M 188M 8.08B | P/E 2024 |
231x | P/E 2025 | 182x |
|---|---|---|---|---|---|
| Enterprise Value | 6.67B 53.6M 47.76M 43.69M 39.79M 75M 5.07B 77.02M 525M 210M 2.68B 201M 197M 8.46B | EV / Sales 2024 |
12.2x | EV / Sales 2025 | 10.1x |
| Free-Float |
59.39% | Yield 2024 |
0.25% | Yield 2025 | 0.64% |
| 1 day | +8.62% | ||
| 1 week | +4.84% | ||
| Current month | +4.84% | ||
| 1 month | +3.03% | ||
| 3 months | -10.85% | ||
| 6 months | -23.73% | ||
| Current year | -30.29% |
| 1 week | 203.2 | 238.4 | |
| 1 month | 203.2 | 273.3 | |
| Current year | 159 | 391.8 | |
| 1 year | 159 | 402 | |
| 3 years | 159 | 726.9 | |
| 5 years | 75 | 1,000 | |
| 10 years | 44 | 1,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 01/01/2014 | |
| Director of Finance/CFO | - | 08/11/2020 | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 01/01/2014 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 05/05/1983 |
| Director/Board Member | 45 | 01/01/2000 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +8.62% | +4.84% | -37.25% | -28.45% | 38.94M | ||
| -3.76% | -0.65% | +47.41% | +140.35% | 1,216B | ||
| -1.45% | -1.05% | +46.41% | +79.94% | 656B | ||
| -2.24% | -0.88% | +32.97% | +103.82% | 509B | ||
| -1.06% | -2.49% | +47.76% | +65.10% | 384B | ||
| -2.27% | +0.42% | +74.12% | +42.14% | 362B | ||
| -0.10% | +1.38% | +32.03% | +60.93% | 311B | ||
| +0.13% | +7.59% | +12.79% | +36.73% | 293B | ||
| -3.80% | -0.10% | +43.90% | +70.56% | 249B | ||
| -3.96% | +1.18% | +36.70% | +105.38% | 208B | ||
| Average | -0.99% | +1.69% | +33.68% | +67.65% | 418.78B | |
| Weighted average by Cap. | -2.31% | +0.03% | +43.53% | +92.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827M 6.64M 5.92M 5.42M 4.93M 9.3M 628M 9.55M 65.06M 26.02M 333M 24.94M 24.4M 1.05B | 665M 5.34M 4.76M 4.35M 3.96M 7.47M 505M 7.67M 52.28M 20.91M 267M 20.04M 19.61M 843M |
| Net income | 42.33M 340K 303K 277K 252K 476K 32.13M 488K 3.33M 1.33M 17.01M 1.28M 1.25M 53.69M | 35.02M 281K 251K 229K 209K 394K 26.58M 404K 2.75M 1.1M 14.08M 1.06M 1.03M 44.42M |
| Net Debt | 290M 2.33M 2.08M 1.9M 1.73M 3.26M 220M 3.35M 22.84M 9.13M 117M 8.76M 8.57M 368M | 302M 2.43M 2.16M 1.98M 1.8M 3.39M 229M 3.49M 23.76M 9.5M 121M 9.11M 8.91M 383M |
Employees
563
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/11/26 | BDT 238.20 | +8.62% | 324,839 |
| 04/11/26 | BDT 219.30 | +6.92% | 202,748 |
| 03/11/26 | BDT 205.10 | -2.93% | 151,295 |
| 02/11/26 | BDT 211.30 | -1.08% | 148,845 |
| 01/11/26 | BDT 213.60 | -5.99% | 191,286 |
- Stock Market
- Stocks
- ORIONINFU Stock
Select your edition
All financial news and data tailored to specific country editions
















